Last edition
News about
ICMR notifies NIMHANS as mentor institution for RT-PCR test protocol for COVID-19
The National Institute of Mental Health and Neuro Sciences (NIMHANS) has been notified by the Indian Council of Medical Research (ICMR) and the Medical Council of India (MCI) as the mentor institution for RT-PCR (Reverse transcription-polymerase chain reaction) test
The U.S. Food and Drug Administration has issued the first emergency use authorization (EUA) for a COVID-19 antigen test, a new category of tests for use in the ongoing pandemic
Lupin's Pithampur Facilities Complete Successful UK MHRA Inspection
Pharma major Lupin Limited (Lupin) today announced the successful close out of the inspection carried out by the Medicines and Healthcare products Regulatory Agency (MHRA), the regulatory agency of the United Kingdom (UK)
Roche today announced that new data from clinical trials of 19 approved and investigational medicines across 21 cancer types, will be presented at the ASCO20 Virtual Scientific Program organised by the American Society of Clinical Oncology (ASCO), which will be held 29-31 May, 2020
FDA Continues to Combat Fraudulent COVID-19 Medical Products
Today, the U.S. Food and Drug Administration is providing an update on the agency's efforts to combat the extremely concerning actions by companies and individuals that are exploiting or taking advantage of widespread fear among consumers during the COVID-19 pandemic
Lupin launches Jan Kovid helpline for Mumbai citizens
Pharma major Lupin Limited announced the launch of the 'Jan Kovid' helpline (1800-572-6130) under the tagline 'Mann Ka Swaasthya, Tann Ki Suraksha' for the residents of Mumbai
Abbott announces CE mark approval for its COVID-19 laboratory based antibody test in India
Abbott announced that it received CE Mark to the IVD Directive (98/79/EC) for its laboratory-based serology blood test for the detection of the antibody, IgG, that identifies if a person has had the novel coronavirus (COVID-19)
Aurobindo Pharma receives US FDA approval for generic Ancobon capsules
Aurobindo Pharma Limited has received final approval from the US Food & Drug Administration (FDA) to manufacture and market flucytosine capsules, 250 mg and 500 mg
Cleveland Clinic establishes center for global and emerging pathogens research
Cleveland Clinic is establishing the Center for Global and Emerging Pathogens Research to broaden understanding of emerging pathogens ranging from Zika virus to SARS-CoV-2 (which causes COVID-19) and to expedite critically needed treatments and vaccines
Roche's COVID-19 antibody test receives FDA Emergency Use Authorization and is available in markets
Roche has already started shipping the new antibody test to leading laboratories globally and will ramp up production capacity to high double-digit millions per month to serve healthcare systems in countries accepting the CE mark2 as well as the U.S.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy